Skip to main content
JRSS logo

JRSS · JRSIS HEALTH CARE Corp

Track JRSS — free
$0.02 At close · Sep 2
Market Cap
$1.52M
Shares
84.60M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.02 Open$0.02 Day$0.02–0.02 52W close$0.01–0.13 Avg vol 30d250K Short int4K · 0.0% float · 1.0d Short vol92% DataJul 2023–Sep 2026 Filing10-Q · Dec 20

Raw chart and full-history price indicators begin at the captured split on Jun 30, 2023; bars on opposite sides are not compared.

Up next

filed Dec 20, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$3.47M
Trailing 12 months
Net income (TTM)
−$503,656
Trailing 12 months
Revenue growth YoY
-55.2%
Year over year
Operating margin
-19.5%
Trailing 12 months
P / E (TTM)
Trailing earnings
FCF yield
TTM · current market cap
Return on invested capital
Trailing 12 months
Net cash
−$30,182
Latest balance sheet
Dividend yield
Trailing 12 months
Shares change YoY
+10.2%
Year over year · more shares
Price change (1Y)
+21.6%
Trailing year
Short interest
Latest settlement
View all 114 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Strong Sell Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 15.2 · calm Equity put/call 0.56
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 50-day avg −43%
below
RSI (14) 44
neutral
MACD trend Negative
52-week position 7%
near low
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Weak
1-month return +12%
trailing
6-month return −96%
trailing
YTD return −17%
this year
Relative strength −111%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Fundamentals
Excellent
Revenue growth +101%
Y/Y
Gross margin 14%
expanding
EPS growth +89%
Y/Y
Free cash flow $515.2K
Balance sheet $908.6K
net debt
Quant / Vol
risk profile
Very High
Volatility 902%
annualized · 1-yr
Max drawdown −100%
past year
ATR 129.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
−43% Bearish
RSI (14)
44 Neutral
MACD trend
Negative Bearish
52-week position
7% Bearish
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
No clear signal
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
0.00% of float · ▬ 0.0% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its 52-week range
Range low $0 Now $0 · 7% Range high $0
vs 50-day avg -43%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Specialty Retail — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
JRSS
JRSIS HEALTH CARE Corp
this stock
$1.52M -17.1% +101.4% 0.0%
CASY
Caseys General Stores Inc
$27.89B +36.3% +10.2% 39.3 3.1%
WSM
Williams Sonoma Inc
$26.19B +24.2% +1.2% 22.8 4.5%
ULTA
Ulta Beauty, Inc.
$23.88B -8.8% +9.7% 20.3 4.7%
BBY
Best Buy Co Inc
$18.34B +30.0% +0.4% 16.1 6.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest
Shares short
4.1K
Days to cover
1.0d
Change
0 sh
View
Short Volume
Short vol %
92%
As of
Jul 10, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jul 20, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$3.5M
Net income (FY)
$-80.9K
EPS diluted
$0.00
View
Filings
SEC Filings
Latest
10-Q
Filed
Dec 20, 2024
This year
0
View

Performance

Raw-price comparisons begin at the captured split on Jun 30, 2023; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
JRSS -26.8% +11.9% -96.4% -16.7% -17.1%
SPY -0.1% -0.6% +14.9% -0.3% +12.2%
vs SPY -26.7% +12.5% -111.3% -16.4% -29.3%
Key facts CIK 1597892